These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 7849715)

  • 21. Differential activity of the cytochrome P450 17alpha-hydroxylase and steroidogenic acute regulatory protein gene promoters in normal and polycystic ovary syndrome theca cells.
    Wickenheisser JK; Quinn PG; Nelson VL; Legro RS; Strauss JF; McAllister JM
    J Clin Endocrinol Metab; 2000 Jun; 85(6):2304-11. PubMed ID: 10852468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CYP17 5'-UTR MspA1 polymorphism and the risk of premenopausal breast cancer in a German population-based case-control study.
    Verla-Tebit E; Wang-Gohrke S; Chang-Claude J
    Breast Cancer Res; 2005; 7(4):R455-64. PubMed ID: 15987450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The CYP17 MspA1 Polymorphism and the Gender Dysphoria.
    Fernández R; Cortés-Cortés J; Esteva I; Gómez-Gil E; Almaraz MC; Lema E; Rumbo T; Haro-Mora JJ; Roda E; Guillamón A; Pásaro E
    J Sex Med; 2015 Jun; 12(6):1329-33. PubMed ID: 25929975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 5' polymorphism of the CYP17 gene is not associated with serum testosterone levels in women with polycystic ovaries.
    Gharani N; Waterworth DM; Williamson R; Franks S
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4174. PubMed ID: 8923880
    [No Abstract]   [Full Text] [Related]  

  • 25. No association between CYP17 -34T/C polymorphism and insulin resistance in Thai polycystic ovary syndrome.
    Techatraisak K; Chayachinda C; Wongwananuruk T; Dangrat C; Indhavivadhana S; Rattanachaiyanont M; Thongnoppakhun W
    J Obstet Gynaecol Res; 2015 Sep; 41(9):1412-7. PubMed ID: 26096606
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CYP17 gene polymorphism and its association in north Indian prostate cancer patients.
    Sobti RC; Gupta L; Thakur H; Seth A; Singh SK; Kaur P
    Anticancer Res; 2009 May; 29(5):1659-63. PubMed ID: 19443382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CYP17 gene analysis in hyperandrogenised women with and without exaggerated 17-hydroxyprogesterone response to ovarian stimulation.
    Liović M; Prezelj J; Kocijancic A; Majdic G; Komel R
    J Endocrinol Invest; 1997 Apr; 20(4):189-93. PubMed ID: 9211124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dysregulation of cytochrome P450 17alpha-hydroxylase messenger ribonucleic acid stability in theca cells isolated from women with polycystic ovary syndrome.
    Wickenheisser JK; Nelson-Degrave VL; McAllister JM
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1720-7. PubMed ID: 15598676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of association between endometriosis and the CYP17 MspA1 polymorphism in UK and Japanese populations.
    Asghar T; Yoshida S; Nakago S; Morizane M; Ohara N; Motoyama S; Kennedy S; Barlow D; Maruo T
    Gynecol Endocrinol; 2005 Feb; 20(2):59-63. PubMed ID: 15823822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association study of CYP17 and HSD11B1 in polycystic ovary syndrome utilizing comprehensive gene coverage.
    Chua AK; Azziz R; Goodarzi MO
    Mol Hum Reprod; 2012 Jun; 18(6):320-4. PubMed ID: 22238371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic variation in the CYP17 gene and recurrent spontaneous abortions.
    Litridis I; Kapnoulas N; Natisvili T; Agiannitopoulos K; Peraki O; Ntostis P; Pantos K; Lamnissou K
    Arch Gynecol Obstet; 2011 Feb; 283(2):289-93. PubMed ID: 20069306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The association between polymorphisms in the CYP17 and 5alpha-reductase (SRD5A2) genes and serum androgen concentrations in men.
    Allen NE; Forrest MS; Key TJ
    Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):185-9. PubMed ID: 11303586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Linkage and association of CYP17 gene in hereditary and sporadic prostate cancer.
    Chang B; Zheng SL; Isaacs SD; Wiley KE; Carpten JD; Hawkins GA; Bleecker ER; Walsh PC; Trent JM; Meyers DA; Isaacs WB; Xu J
    Int J Cancer; 2001 Nov; 95(6):354-9. PubMed ID: 11668516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relationship between a polymorphism in CYP17 with plasma hormone levels and prostate cancer.
    Haiman CA; Stampfer MJ; Giovannucci E; Ma J; Decalo NE; Kantoff PW; Hunter DJ
    Cancer Epidemiol Biomarkers Prev; 2001 Jul; 10(7):743-8. PubMed ID: 11440959
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostate cancer associated with CYP17 genotype.
    Wadelius M; Andersson AO; Johansson JE; Wadelius C; Rane E
    Pharmacogenetics; 1999 Oct; 9(5):635-9. PubMed ID: 10591544
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The human 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD) gene cluster on chromosome 1p13 contains a presumptive pseudogene; 3 beta-HSD and CYP17 do not segregate with dominantly inherited hirsutism.
    McBride MW; Russell AJ; Vass K; Frank-Raue K; Craig NJ; Morrison N; Boyd E; Szpirer C; Sutcliffe RG
    J Mol Endocrinol; 1995 Oct; 15(2):167-76. PubMed ID: 8800641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CYP17 (T-34C) and CYP19 (Trp39Arg) polymorphisms and their cooperative effects on breast cancer susceptibility.
    Tüzüner BM; Oztürk T; Kisakesen HI; Ilvan S; Zerrin C; Oztürk O; Isbir T
    In Vivo; 2010; 24(1):71-4. PubMed ID: 20133979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CYP11A1 and CYP17 promoter polymorphisms associate with hyperandrogenemia in polycystic ovary syndrome.
    Pusalkar M; Meherji P; Gokral J; Chinnaraj S; Maitra A
    Fertil Steril; 2009 Aug; 92(2):653-9. PubMed ID: 18725155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A complex heterozygous mutation of His373Leu and Asp487-Ser488-Phe489 deletion in human cytochrome P450c17 causes 17alpha-hydroxylase/17,20-lyase deficiency in three Chinese sisters.
    Qiao J; Hu RM; Peng YD; Song HD; Peng YW; Gao GF; Hao JH; Hu NY; Xu MY; Chen JL
    Mol Cell Endocrinol; 2003 Mar; 201(1-2):189-95. PubMed ID: 12706306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Seventeen alpha-hydroxylase deficiency with one base pair deletion of the cytochrome P450c17 (CYP17) gene.
    Oshiro C; Takasu N; Wakugami T; Komiya I; Yamada T; Eguchi Y; Takei H
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2526-9. PubMed ID: 7629254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.